The field of cardiac tissue engineering has made significant strides over the last few
decades, highlighted by the development of human cell derived constructs that have shown …

Cardiovascular diseases such as myocardial infarction account for millions of worldwide
deaths annually. Cardiovascular tissues constitute a highly organized and complex three …

Cardiac cell therapy suffers from limitations related to poor engraftment and significant cell
death after transplantation. In this regard, ex vivo tissue engineering is a tool that has been …

We used rat experimental myocardial infarction to study the ultrastructural recovery,
especially neo‐angiogenesis in the infarction border zone. We were interested in the …

Since cardiovascular diseases are the number one cause of death in worldwide, and the
traditional treatments have limitations, the emergence of cardiac tissue engineering (CTE) …

Acute myocardial infarction (MI) leads to morbidity and mortality due to cardiac dysfunction.
Here we identify sericin, a silk-derived protein, as an injectable therapeutic biomaterial for …

Myocardial infarction (MI) can be tackled by implanting cardiac patches which provide
mechanical support to the heart. However, most tissue-engineered scaffolds face difficulty in …

Solubilized cardiac extracellular matrix (ECM) is being developed as an injectable
therapeutic that offers promise for promoting cardiac repair. However, the ECM alone forms …

Cardiovascular diseases (CVDs) are one of the most important causes of mortality and
affecting the health status of patients. At the same time, CVDs cause a huge health and …

The use of biomaterials has been demonstrated as a viable strategy to promote cell survival
and cardiac repair. However, limitations on combinational cell–biomaterial therapies exist …